Researchers discovered how anti-cancer drugs called HDAC inhibitors help treat pancreatic cancer by altering scar tissue (fibroblast) development. The findings suggest HDAC inhibitors could be powerful tools in fighting pancreatic cancer -- alone and in combination with other therapies.
Read more https://www.sciencedaily.com/releases/2023/12/231206115918.htm